AA33626
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
250mg | 96% | in stock | $15.00 | $11.00 | - + | |
1g | 96% | in stock | $34.00 | $24.00 | - + | |
5g | 96% | in stock | $97.00 | $68.00 | - + | |
10g | 96% | in stock | $173.00 | $121.00 | - + | |
25g | 96% | in stock | $388.00 | $272.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AA33626 |
Chemical Name: | 1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)piperidine |
CAS Number: | 120014-07-5 |
Molecular Formula: | C24H27NO3 |
Molecular Weight: | 377.4761 |
MDL Number: | MFCD08693144 |
SMILES: | COc1cc2c(cc1OC)C/C(=C\C1CCN(CC1)Cc1ccccc1)/C2=O |
Complexity: | 560 |
Covalently-Bonded Unit Count: | 1 |
Defined Bond Stereocenter Count: | 1 |
Heavy Atom Count: | 28 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 5 |
XLogP3: | 4.2 |
The compound 2-((1-Benzylpiperidin-4-yl)methylene)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one has a unique chemical structure that makes it a valuable tool in chemical synthesis processes. Its specific molecular configuration allows for versatile applications in organic reactions, providing a key building block for the creation of various complex molecules.This compound exhibits reactivity at the piperidine nitrogen and the carbonyl group, making it suitable for use in the synthesis of heterocyclic compounds and pharmaceutical intermediates. Its methoxy groups enhance its solubility and stability, making it a convenient reagent in multistep synthesis strategies.In chemical synthesis, this compound can serve as a starting material for the construction of diverse molecular scaffolds, such as indenone derivatives and substituted piperidines. Its structural features enable it to participate in a range of transformations, including condensation reactions, nucleophilic additions, and cyclizations, leading to the formation of intricate organic molecules with potential biological activities.